Implanet Granted 501(k) Clearance to Launch Jazz Claw Implant
Medical technology company Implanet announces it has received regulatory clearance—510(k) in the US and CE Mark in Europe—to market the Jazz Claw hybrid implant.
Medical technology company Implanet announces it has received regulatory clearance—510(k) in the US and CE Mark in Europe—to market the Jazz Claw hybrid implant.
Researchers from Mount Sinai have designed a new x-ray classification system for adult idiopathic scoliosis that they suggest could more precisely define which parts of the spine need correction.